Enhanced proliferative activity of PIXY-321, the granulocyte-macrophage colony-stimulating factor and interleukin-3 fusion protein

Leukemia and Lymphoma

Volumn 29, Issue 1-2, 1998, Pages 119-128

  Drexler, Hans G ^a   Meyer, Corinna ^a  

^a Dept Hum Anim Cell Cultures B ^*  (Germany)

Author keywords

Cell lines; GM CSF; IL 3; Leukemia; PIXY 321

Indexed keywords

DNA; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYBRID PROTEIN; INTERLEUKIN 3; MILODISTIM;

ARTICLE; CELL LINE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DNA SYNTHESIS; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL;

EID: 0031806319     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809058387     Document Type: Article

References (28)

1. Callard, R. and Gearing, A. (eds.) (1994). The Cytokine FactsBook. (London, Academic Press.)
2. Nicola, N. A. (1994). Granulocyte-macrophage colony-stimulating factor (GM-CSF). In: Guidebook to Cytokines and Their Receptors N.A. Nicola, (ed.), pp. 171-173. (Oxford University Press, Oxford.)
3. Schrader, J. W. (1994). Interleukin-3 (IL-3). In: Guidebook to Cytokines and Their Receptors, N.A. Nicola, (ed), pp. 38-40. (Oxford University Press, Oxford.)
4. Nicola, N. A. (ed.) (1994). Guidebook to Cytokines and Their Receptors. (Oxford University Press, Oxford.)
5. Curtis, B. M., Williams, D. E., Broxmeyer, H. E., Dunn, J., Farrah, T., Jeffery, E., Clevenger, W., de Roos, P., Martin, U., Friend, D., Craig, V., Gayle, R., Price, V., Cosman, D., March, C. J. and Park, L. S. (1991). Enhanced hematopoietic activity of a human granulocyte/macrophage colony-stimulating factor-interleukin 3 fusion protein. Proc. Natl. Acad. Sci. USA, 88, 5809-5813.
6. Drexler, H. G., Gignac, S. M. and Minowada, J. (1994). Hematopoietic cell lines. In: Atlas of Human Tumor Cell Lines R.J. Hay, J.G. Park and A. Gazdar, (eds), pp. 213-250 (Academic Press, Orlando).
7. Drexler, H. G., Dirks, W., MacLeod, R. A. F., Quentmeier, H. and Steube, K. (eds) (1995). DSM Catalogue of Human and Animal Cell Lines, 5th edn. DSMZ, Braunschweig, Germany.
8. Oez, S., Tittelbach, H., Fahsold, R., Schaetzl, R., Bührer, C., Atzpodien, J. and Kalden, J. R. (1990). Establishment and characterization of a granulocyte-macrophage colony-stimulating factor-dependent human myeloid cell line. Blood, 76, 578-582.
9. Morgan, D. (1993). Differential cytokine response of human lineage specific progenitor cell lines. Blood, 82, 373a.
10. Avanzi, G. C., Lista, P., Giovinazzo, B., Miniero, R., Saglio, G., Benetton, G., Coda, R., Cattoretti, G. and Pegoraro, L. (1988). Selective growth response to IL-3 of a human leukaemic cell line with megakaryoblastic features. Brit. J. Haematol., 69, 359-366.
11. Morgan, D. A., Gumucio, D. L. and Brodsky, I. (1991). Granulocyte-macrophage colony-stimulating factor-dependent growth and erythropoietin-induced differentiation of a human cell line MB-02. Blood, 78, 2860-2871.
12. Itano, M., Tsuchiya, S., Minegishi, N., Fujie, H., Minegishi, M., Monta, S., Yambe, T., Ohashi, Y., Masuda, T., Koike, T. & Konno, T. (1995). Establishment and characterization of a novel human immature megakaryoblastic leukemia cell line, M-MOK, dependent on fibroblasts for its viability. Exp. Hematol., 23, 1301-1309.
13. Hu, Z. B., Ma, W., Zaborski, M., MacLeod, R. A. F., Quentmeier, H. and Drexler, H. G. (1996). Establishment and characterization of two novel cytokine-responsive acute myeloid and monocytic leukemia cell lines, MUTZ-2 and MUTZ-3. Leukemia, 10, 1025-1040.
14. Wang, C., Curtis, J. E., Minden, M. D. and McCulloch, E. A. (1989). Expression of a retinoic acid receptor gene in myeloid leukemia cells. Leukemia, 3, 264-269.
15. Wang, C., Koistinen, P., Yang, G. S., Williams, D. E., Lyman, S. D., Minden, M. D. and McCulloch, E. A. (1991). Mast cell growth factor, a ligand for the receptor encoded by c-kit, affects the growth in culture of the blast cells of acute myeloblastic leukemia. Leukemia, 5, 493-499.
16. Tohda, S., Yang, G. S., Ashman, L. K., McCulloch, E. A. and Minden, M. D. (1993). Relationship between c-KIT expression and proliferation in acute myeloblastic leukemia cell lines. J. Cell. Physiol., 154, 410-418.
17. Matozaki, S., Nakagawa, T., Kawaguchi, R., Aozaki, R., Tsutsumi, M., Murayama, T., Koizumi, T., Isobe, R. N. T. and Chihara, K. (1995). Establishment of a myeloid leukaemic cell line (SKNO-1) from a patient with t(8;21) who acquired monosomy 17 during disease progression. Brit. J. Haematol., 89, 805-811.
18. Kitamura, T., Tange, T., Terasawa, T., Chiba, S., Kuwaki, T., Miyagawa, K., Piao, Y. F., Miyazono, K., Urabe, A. and Takaku, F. (1989). Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J. Cell. Physiol, 140, 323-334.
19. Komatsu, N., Nakauchi, H., Miwa, A., Ishihara, T., Eguchi, M., Moroi, M., Okada, M., Sato, Y., Wada, H., Yawata, Y., Suda, T. and Miura, Y. (1991). Establishment and characterization of a human leukemic cell line with megakaryocytic features: Dependency on granulocyte-macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival. Cancer Res., 51, 341-348.
20. Fleckenstein, E., Uphoff, C. C. and Drexler, H. G. (1994). Effective treatment of mycoplasma contamination in cell lines with enrofloxazin (Baytril). Leukemia, 8, 1424-1434.
21. Quentmeier, H., Zaborski, M. and Drexler, H. G. (1992). The human bladder carcinoma cell line 5637 constitutively secretes functional cytokines. Leukemia Res., (in press), 21:343-350.
22. Williams, D. E. and Park, L. S. (1991). Hematopoietic effects of a granulocyte-macrophage colony-stimulating factor/ interleukin-3 fusion protein. Cancer, 67 (suppl.), 2705-277.
23. Bhalla, K., Tang, C., Ibrado, A. M., Grant, S., Tourkina, E., Holladay, C., Hughes, M., Mahoney, M. E. and Huang, Y. (1992). Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY321) enhances high-dose Ara-C-induced programmed cell death or apoptosis in human myeloid leukemia cells. Blood, 80, 2883-2890.
24. Drach, D., Estrov, Z., Zhao, S., Drach, J., Cork, A., Collins, D., Kantarjian, H. and Andreeff, M. (1994). Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor, PIXY-321, stem cell factor, interleukin-3, and interleukin-7: Receptor binding and effects on clonogenic proliferation in acute lymphoblastic leukemia. Leukemia Lymphoma, 16, 79-88.
25. Gore, S. D., Weng, L. J. and Burke, P. J. (1994). Identification of growth factor-responsive acute myelogenous leukemia based on factor-dependence for survival and proliferation. Leukemia, 11, 1854-1863.
26. Bishop, M. R., Jackson, J. D., O'Kane-Murphy, B., Schmit-Pokarny, K., Vose, J. M., Bierman, P. J., Warkentin, P. I., Armitage, J. O., Garrison, L. and Kessinger, A. (1996). Phase 1 trial of recombinant fusion protein PIXY321 for mobilization of peripheral-blood cells. J. Clin. Oncol., 14, 2521-2526.
27. Vadhan-Raj, S., Papadopoulos, N. E., Burgess, M. A., Linke, K. A., Patel, S. R., Hays, C., Arcenas, A., Plager, C., Kudelka, A. P., Hittelman, W. N., Broxmeyer, H. E., Williams, D. E., Garrison, L. and Benjamin, R. S. (1994). Effects of PIXY321, a granulocyte-macrophage colony stimulating factor interleukin-3 fusion protein, on chemotherapy-induced multilineage myelosuppression in patients with sarcoma. J. Clin. Oncol., 12, 715-720.
28. Mignacca, R. C., Lee, H. J. J., Kwon, E. M. and Sakamoto, K. M. (1996). Mechanism of transcriptional activation of the immediate early gene egr-1 in response to PIXY321. Blood, 88, 848-854.